The Pharmaceutical Journal
Vol 275 ppF1-F36 
October 2005

FIP 2005 Cairo

Other FIP reports
Reports   Back issues

PJ Online home  |  Search PJ Online

 Acrobat Reader

FIP Congress supplement (Cairo, 2005)

The World Congress of Pharmacy and Pharmaceutical Sciences was organised by the International Pharmaceutical Federation in association with the Syndicate of Pharmacists of the Arab Republic of Egypt.
It took place in Cairo from September 2 to 8, 2005

The editorial content of this supplement is the responsibility of The Pharmaceutical Journal alone. Correspondence should be addressed to
Graeme Smith
tel +44 (0)20 7572 2426
email graeme.smith@pharmj.org.uk

List of Contents

Community Pharmacy Section
- Improving adherence in community pharmacy
- Promoting public health

FIP President & Young Pharmacists Group
- International co-ordination of medicines donations after disasters
- Counterfeit and substandard medicines (with Pharmacy Information Section)
- Moral and ethical issues surrounding migration of health care professionals

Pharmacy practice programme
- Problems associated with production, supply, distribution and control of the quality of medicines

Academic Pharmacy Section / International Pharmaceutical Students Federation
- How social pharmacy is taught, and presentations on e-learning

Administrative Pharmacy Section
- Usefulness of qualitative research
- Doctor-Pharmacist case conferences bring about promising outcomes

Pharmacy Information Section
- Adherence to antiretroviral therapy
- Counterfeit and substandard medicines (with Young Pharmacists Group)

Hospital Pharmacy Section
- Controlling costs of medicines
- Human resources in hospital pharmacy

FIP / International Pharmaceutical Students Association
- Access to medicines and equity in health care

Military and Emergency Pharmacy Section
- Preparing for an influenza pandemic

Board of Pharmaceutical Sciences
- Biopharmaceutics and dosage aspects of the drug development process

- Biotechnology products in medicine (with American Association of Pharmaceutical Scientists and Academy of Pharmaceutical Sciences and Technology of Japan)

- Good chemistry, manufacturing and industrial practice (with Industrial Pharmacy Section)

Special Interest Group
- Natural product research

Jobs and Classified advertising



Community Pharmacy Section   F2, F17

Improving adherence in community pharmacy

The Community Pharmacy section organised a pre-congress satellite symposium on 3 September 2005 to look at what affects adherence and what works in the community pharmacy sector for improving it. James McElnay reports

Who cares about compliance, adherence or concordance? The pharmacist cares F2
PJ   2005;275 (suppl) F2
Full Text   PDF (90K)

Health care professionals need tools to find out if patients adhere to their medication regimens F2
PJ   2005;275 (suppl) F2
Full Text   PDF (90K)

Promoting public health

What does promoting public health mean to health care professionals F17
Graeme Smith reports from a session on promoting public health on 6 September 2005 organised by the Community Pharmacy Section
PJ   2005;275 (suppl) F17
Full Text   PDF (90K)

Top

FIP   F3-F4, F22, F25-F26

International co-ordination of medicines donations after disasters

Over 2,000 participants from 93 countries heard the president of the International Pharmaceutical Federation call on member organisations to create specialist units to co-ordinate international donations of medicines after disasters such as the Asian tsunami. Graeme Smith reports

FIP organisations must co-ordinate medicines donations after disasters F3-F4
PJ   2005;275 (suppl) F3-F4
Full Text   PDF (210K)

Top FIP awards go to British pharmacists F4
PJ   2005;275 (suppl) F3-F4
Full Text   PDF (210K)

FIP Young Pharmacists Group

Information sharing to address counterfeit and substandard drugs F22
A joint session of the Pharmacy Information Section and Young Pharmacists' Group was organised on 5 September to address the issue of combating counterfeit and substandard medicines. Jane Nicholson reports
PJ   2005;275 (suppl) F22
Full Text   PDF (40K)

Plugging the pharmacy brain drain F25-F26
FIP's Young Pharmacists Group held a symposium on 7 September on the moral and ethical issues surrounding the migration of health care professionals. Speakers look at the issue from a range of perspectives and suggested possible solutions. Lindsay McClure reports
PJ   2005;275 (suppl) F25-F26
Full Text   PDF (150K)

Top

Pharmacy practice programme    F5-F14

Problems associated with production, supply, distribution and control of the quality of medicines

Problems of access to medicine are not confined to developing countries. Under the general title “The right medicine to the right person — can we guarantee it anywhere in the world?”, the five symposia of the congress’s pharmacy practice programme examined the problems associated with the production, supply, distribution and control of the quality of medicines. Pamela Mason and Graeme Smith report

The world's poor are still poor when it comes to access to medicines F5
PJ   2005;275 (suppl) F5
Full Text   PDF (110K)

Telepharmacy increases access in the rural US F6
PJ   2005;275 (suppl) F6
Full Text   PDF (110K)

Alleviating the shortage of human resources in developing countries F6
PJ   2005;275 (suppl) F6
Full Text   PDF (110K)


Medicines prices rising more rapidly than those of other goods worldwide F7
PJ   2005;275 (suppl) F7
Full Text   PDF (110K)

Are patents a barrier to availability of medicines? F8
PJ   2005;275 (suppl) F8
Full Text   PDF (110K)


Problems associated with medicines selection, supply and distribution F9-F10
PJ   2005;275 (suppl) F9-10
Full Text   PDF (130K)

Problems and dangers of counterfeit medicines — a major health concern F11-F12
PJ   2005;275 (suppl) F11-F12
Full Text   PDF (110K)

Medicines prices are not just about research and development costs F13-F14
PJ   2005;275 (suppl) F13-F14
Full Text   PDF (160K)

Top

Academic Pharmacy section   F15-F16

Concepts of social and administrative pharmacy need to be defined F15-F16
At a joint symposium of FIP's Academic Pharmacy Section and the International Pharmaceutical Students Federation on 5 and 6 September learnt how social pharmacy is taught to students, and heard presentations on e-learning. Jennifer Archer reports
PJ   2005;275 (suppl) 15-F16
Full Text   PDF (80K)

Top

Administrative Pharmacy section    F18-F20

Usefulness of qualitative research F18
At a session organised by the Administrative Pharmacy Section on 6 September entitled “Evaluation studies as a basis for decision making”, Claire Anderson was one of the speakers. She reports the session here
PJ   2005;275 (suppl) F18
Full Text   PDF (40K)

Doctor-pharmacist case conferences bring about promising outcomes F19-F20
The Administrative Pharmacy Section organised a symposium entitled “Changing the professional status — the way forward to integrated care” on 7 September. Graeme Smith reports
PJ   2005;275 (suppl) F19-F20
Full Text   PDF (230K)

Top

Pharmacy Information section   F20-F22

HIV/AIDS — models to help enhance adherence and positive outcomes F20-F21
A session of the Pharmacy Information Section on 6 September examined the ways in which adherence to antiretroviral therapy can be supported. Pamela Mason reports
PJ   2005;275 (suppl) F20-F21
Full Text   PDF (230K)

Information sharing to address counterfeit and substandard drugs F22
A joint session of the Pharmacy Information Section and Young Pharmacists' Group was organised on 5 September to address the issue of combating counterfeit and substandard medicines. Jane Nicholson reports
PJ   2005;275 (suppl) F22
Full Text   PDF (40K)

Top

Hospital Pharmacy section    F23-F24

Controlling costs of medicines — how are those used in hospitals paid for? F23
Roger Tredree reports from a Hospital Pharmacy Section session on 7 September
PJ   2005;275 (suppl) F23
Full Text   PDF (80K)

How service provision in hospitals is affected by the pharmacy workforce F24
Human resources in hospital pharmacy was the subject of a Hospital Pharmacy Group session on 7 September. Roger Tredree reports
PJ   2005;275 (suppl) F24
Full Text   PDF (40K)

Top

FIP / International Pharmaceutical Students Association   F26

Enhancing access in Tanzania F26
A session jointly organised by FIP and the International Pharmaceutical Students Association on 6 September looked at issues surrounding access to medicines and equity in health care. Lindsay McClure reports
PJ   2005;275 (suppl) F26
Full Text   PDF (150K)

Top

Military and Emergency Pharmacy Section   F27

Preparing for an influenza pandemic F27
Graeme Smith reports from a session organised by the Military and Emergency Pharmacy section on 8 September
PJ   2005;275 (suppl) F27
Full Text   PDF (60K)

Top

Board of Pharmaceutical Sciences   F28-F31, F34-F35

Biopharmaceutics and dosage aspects of the drug development process F28-F29
Geoffrey Phillips reports from a Board of Pharmaceutical Sciences symposium on 5 September
PJ   2005;275 (suppl) F28-F29
Full Text   PDF (80K)

Pharmaceutical biotechnology and its impact in the post-genomic era F30-F31
Some of the most current issues relating to the use of biotechnology products in medicine were discussed at a symposium on 6 September jointly organised by the FIP Board of Pharmaceutical Sciences, the American Association of Pharmaceutical Scientists and the Academy of Pharmaceutical Sciences and Technology of Japan. Gavin Brooks, who chaired the session, reports
PJ   2005;275 (suppl) F30-F31
Full Text   PDF (80K)

What good chemistry, manufacturing and control practice will be in future F34-F35
In a symposium organised by the Board of Pharmaceutical Sciences and the Industrial Pharmacy Section, issues surrounding good chemistry, manufacturing and industrial practice were discussed. Jane Nicholson reports
PJ   2005;275 (suppl) F34-F35
Full Text   PDF (90K)

Top

Special Interest Group   F32-F33

Natural product research in Egypt and the role of phytopharmaceuticals F32-F33
Natural product research was the subject of the inaugural meeting of FIP's special interest group (superseding the Medicinal and Aromatic Plants Section) on natural substances on 7 September. Geoffrey Phillips reports
PJ   2005;275 (suppl) F32-F33
Full Text   PDF (230K)

Top

©The Pharmaceutical Journal